Results 221 to 230 of about 49,899 (288)

Prognostic Significance of B7-H3 Expression and CD163+ Tumor-Associated Macrophage Infiltration in Mesothelioma. [PDF]

Int J Mol Sci
Koç T, Yüceer RO, Altay T, Taş N, Çelikgün S.   +4 more
europepmc   +1 more source

Lichenoid and Granulomatous Stomatitis: Three Additional Cases and Detailed Immunohistochemical Analysis

Journal of Cutaneous Pathology, Volume 53, Issue 12, Page 1074-1079, December 2026.
ABSTRACT Background Lichenoid and granulomatous stomatitis (LGS) is a rare condition, with clinicopathological features resembling lichenoid and granulomatous dermatitis. Despite increasing reports, its etiology remains unclear and detailed immunohistochemical (IHC) studies are lacking.
Mariana Paravani Palaçon, Karina Kendelhy Santos, Karina Helen Martins, Cecília Aparecida de Oliveira Campos, Ana Terezinha Marques Mesquita, Evânio Vilela Silva, Thales Peres Candido Moreira, Gabriel Enrique Tantalean Laor, Victor Hugo Toral‐Rizo, Alan Grupioni Lourenço, Heitor Albergoni Silveira, Jorge Esquiche León, Andreia Bufalino   +12 more
wiley   +1 more source

PD-L1 Expression and Immune Microenvironment Remodeling During Laryngeal Carcinogenesis: Implications for Malignant Progression of Laryngeal Dysplasia. [PDF]

Int J Mol Sci
Tudor F, Marijić B, Babarović E, Hadžisejdić I.   +3 more
europepmc   +1 more source

Evaluation of Methods for Identifying Human Monocytes by Flow Cytometry: TLR2 May be an Optimal Marker

Immunology, Volume 179, Issue 4, Page 682-694, December 2026.
Monocytes play crucial roles in the pathobiology of a wide range of medical conditions, including infection, autoimmunity, cardiovascular disease and malignancies. Studies using flow cytometry revealed the complexity of monocyte biology, including the identification of three human monocyte subsets: classical (CD14pos CD16neg), intermediate (CD14pos ...
Mie Wolff Kristensen, Katrine Skjøt Harbo, Thomas Vorup‐Jensen, Marianne Hokland, Morten Nørgaard Andersen   +4 more
wiley   +1 more source

Association of intratumoral CD68⁺CD163⁺ M2-like macrophages with survival in metastatic colorectal cancer treated with chemotherapy plus bevacizumab. [PDF]

Front Immunol
Xin X, Qiu H, Zang Y, Zhou L, Qin T, Kong Q.   +5 more
europepmc   +1 more source

Single-cell transcriptomics provides insights into the stress-immune interplay and informs disease risk. [PDF]

Cell Genom
Benavides S, Kosyk O, Wang H, Bastian AG, Georgiou C, Miller BC, Stanley N, Zannas AS.   +7 more
europepmc   +1 more source

Bioadhesive‐Integrated 3D‐Printed Multilayer Scaffolds Secure a Mechanically‐Stable Osteoimmune Niche for Enhanced Bone Augmentation

Advanced Science, Volume 13, Issue 61, 3 November 2026.
A 3D‑printed multilayer adhesive scaffold, firmly anchored to bone defects by simple finger pressing, suppresses micromotion and secures mechanical stability of the osteogenic niche. This stabilization likely contributes to the enhanced bone augmentation by fostering a pro‑regenerative mechano‐immune profile—characterized by M2‑like macrophage ...
Delu Zhao, Qiuyi Li, Lingyun Wang, Chongao Zhang, Yutian Cheng, Shuang Liu, Fulan Wei, Zheqin Dong   +7 more
wiley   +1 more source

Brain perivascular macrophages regulate endothelial cell function via a cMAF-dependent transcriptional program in mouse and human. [PDF]

Cell
Brioschi S, Belk JA, Storck SE, Wu Y, Wang Z, Feng Z, van Olst L, Emery JL, Sudan R, Wu J, Du S, Genua M, La Terza F, Edwards AJ, Nguyen KM, Sanford J, Lee DD, Bugatti M, Federico AJ, Chen Y, Wang Z, Penati S, Rodrigues PF, Antonova AU, Loo HQ, Smirnov I, Gilfillan S, Halabi CM, Ponce J, Yan J, Chang HY, Randolph GJ, Vermi W, Cella M, Meers M, Ostuni R, Gate D, Nguyen AT, Cruchaga C, Hu S, Kipnis J, Colonna M.   +41 more
europepmc   +1 more source

Plaque‐Hepatic Targeting Nanotherapy Disrupts the PCSK9‐LOX‐1 Axis to Suppress oxLDL in Atherosclerosis

Advanced Science, Volume 13, Issue 61, 3 November 2026.
Self‑amplifying PCSK9–LOX‑1 feedback axis drives atherosclerotic progression by promoting oxLDL generation and endothelial uptake. A dual‑targeting nanoplatform (siPCSK9@PEAL NPs‑aL) is constructed to simultaneously silence hepatic PCSK9 for lipid lowering and block plaque LOX‑1 for anti‑inflammation.
Yi Duan, Yijie Qiu, Yan Zhu, Quan Wang, Jiangtao Lin, Yourong Duan, Qi Wang, Yi Dong   +7 more
wiley   +1 more source